MODULATION OF VIRUS-SPECIFIC IMMUNITY IN VITRO BY THE ADDITION OF INTERLEUKIN-1 AND INTERLEUKIN-2 IN PATIENTS WITH THE ACQUIRED IMMUNE DEFICIENCY SYNDROMEa

Authors

  • J. F. Sheridan,

    1. Department of Pharmacology and Experimental Therapeutics The University of Maryland School of Medicine
    2. The Johns Hopkins Sexually Transmitted Diseases Research Unit
    Search for more papers by this author
  • L. Aurelian,

    1. Department of Pharmacology and Experimental Therapeutics The University of Maryland School of Medicine
    2. The Johns Hopkins Sexually Transmitted Diseases Research Unit
    Search for more papers by this author
  • T. C. Quinn

    1. Department of Medicine The Johns Hopkins Medical Institutions Baltimore, Maryland 21224
    Search for more papers by this author

  • a

    These studies were supported by Public Health Service Grant AI 16959 from the National Institute of Allergy and Infectious Diseases.

Ancillary